Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice

This publication has 25 references indexed in Scilit:

• 2-Thiazolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice
  Pharmacology Biochemistry and Behavior, 1994
• Histaminergic modulation and chemically-induced seizures in mice
  Inflammation Research, 1992
• Desentization of histamine H1 receptor-mediated cyclic GMP production in guinea-pig lung
  European Journal of Pharmacology: Molecular Pharmacology, 1992
• Histamine in brain — its role in regulation of seizure susceptibility
  Epilepsy Research, 1991
• Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell-deficient W/Wv mice
  Life Sciences, 1991
• Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: The importance of muscarinic step in central cholinergic neurons
  Inflammation Research, 1991
• Effects of the Histamine H₃-Agonist (R)-?-Methylhistamine and the Antagonist Thioperamide on Histamine Metabolism in the Mouse and Rat Brain
  Journal of Neurochemistry, 1989
• Highly potent and selective ligands for histamine H3-receptors
  Nature, 1987
• Is histamine an anticonvulsive inhibitory transmitter?
  Neuropharmacology, 1986
• Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
  Nature, 1983